#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16272	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2020	796.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1695	1695	T	882	T	801	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16272	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2020	796.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	930	C	849	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	16272	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2020	796.0	0	HET	.	.	.	C226T	.	226	226	C	471	471	C	899	C,T	621,188	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3491	867.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1662	1662	A	1063	A,G	960,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3491	867.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	965	C	858	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3491	867.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	927	A	840	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30486	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3491	867.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2922	2922	C	910	C	827	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	20	blaTEM	861	431	100.0	blaTEM.l6.c4.ctg.1	431	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2322	folP	855	855	99.88	folP.l6.c4.ctg.1	1356	169.4	1	SNP	p	R229S	1	.	.	685	687	AGC	962	964	AGC	217;221;219	A;G;C,A	194;200;196,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6394	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3287	193.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	553	555	GCC	206;208;208	G;C;C,A	176;177;178,1	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	6394	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3287	193.1	1	SNP	p	S91F	1	.	.	271	273	TTC	541	543	TTC	212;213;214	T;T;C,T	187;188;187,1	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1878	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1187	157.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	373	375	ACC	231;232;233	A;C;C	197;203;204	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1878	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1187	157.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	571	573	CAC	253;256;257	C;A;C	228;228;229	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1878	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1187	157.2	0	.	p	.	0	A127fs	FSHIFT	379	379	G	637	637	G	236	G	212	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1878	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1187	157.2	1	SNP	p	G45D	0	.	.	133	135	GGC	391	393	GGC	238;235;237	G;G;C	222;220;223	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	944	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	769	121.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5572	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2870	192.7	0	.	p	.	0	S87N	NONSYN	259	261	AGT	507	509	AAT	250;248;247	A;A;T	228;226;225	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5572	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2870	192.7	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1551	1553	GCA	229;226;230	G;C;A	205;196;199	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5572	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2870	192.7	1	SNP	p	D86N	0	.	.	256	258	GAC	504	506	GAC	246;245;246	G;A;C	224;218;224	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5572	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2870	192.7	1	SNP	p	S88P	0	.	.	262	264	TCC	510	512	TCC	246;247;250	T;C,T;C	227;226,1;231	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5000	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2533	195.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1509	1511	GGC	247;247;245	G;G;C	227;223;222	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1279	1281	GCA	258;258;258	G;C;A	232;230;235	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1282	1284	ATC	259;258;259	A;T;C	235;235;235	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1294	1296	GTG	259;257;260	G;T;G	235;232;235	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1294	1296	GTG	259;257;260	G;T;G	235;232;235	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1798	1800	ACC	223;224;226	A;C;C	198;205;206	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1852	1854	GCG	204;202;205	G;C;G	172;146;154	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1852	1854	GCG	204;202;205	G;C;G	172;146;154	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1975	1977	GGT	216;211;214	G;G;T	193;193;192	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1984	1986	GGC	214;214;216	G;G;C	191;190;191	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	4622	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2429	189.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2002	2004	CCG	198;199;195	C,G;C;G	146,1;149;146	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6760	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3177	211.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1723	1725	CCG	235;233;229	C;C;G,A	202;210;200,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2586	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1858	138.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	578	578	C	199	C,G	170,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	96	98	TTA	61;63;63	T;T;A	54;58;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	S271T	NONSYN	811	813	TCG	135	137	ACT	80;80;80	A;C;T	75;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	141	143	CAT	66;66;62	C;A;T	60;59;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	144	146	AGT	62;62;62	A;G;T	57;55;57	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	153	155	TAC	64;65;66	T;A;C	58;58;58	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	243	245	GAA	23;23;23	G;A;A	23;23;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	255	257	GCA	22;22;22	G;C;A	21;22;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	264	266	ATC	22;22;22	A;T;C	22;21;22	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	270	272	TCG	20;20;19	T;C;G	19;20;18	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	276	278	GCC	18;17;17	G;C;C	18;17;16	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	279	281	AGC	17;17;18	A;G;C	17;17;16	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	282	284	GCC	17;17;17	G;C;C	14;15;15	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	370	porB1a	984	271	91.88	porB1a.l6.c30.ctg.2	418	35.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	288	290	GTT	15;15;15	G,T;T;T	13,1;15;13	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	0	.	p	.	0	R143K	NONSYN	427	429	AGA	689	691	AAA	247;247;250	A;A;A	220;221;221	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	0	.	p	.	0	.	INDELS	629	630	AA	892	894	TAG	234;238;237	T;A;G	219;225;221	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	896	899	CAAT	241;241;243;242	C;A;A;T	225;226;229;225	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	901	901	T	241	T	224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	1	SNP	p	G120K	0	.	.	358	360	GGT	620	622	GGT	255;255;254	G;G;T	233;230;225	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	1	SNP	p	A121D	0	.	.	361	363	GCC	623	625	GCC	251;250;245	G,A;C;C	224,1;229;228	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3082	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1448	210.3	1	SNP	p	A121N	0	.	.	361	363	GCC	623	625	GCC	251;250;245	G,A;C;C	224,1;229;228	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11738	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4700	248.1	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1884	1886	AAT	248;246;247	A,C;A,G;T	225,2;224,1;223	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1220	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	837	143.5	1	SNP	p	V57M	1	.	.	169	171	ATG	430	432	ATG	248;249;248	A;T;G	228;229;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	M177T	NONSYN	529	531	ATG	920	922	ACG	480;473;473	A,G;C;G	450,1;451;451	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	941	943	GAC	393;395;394	G;A;C	389;390;391	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	T190M	NONSYN	568	570	ACG	959	961	ATG	373;376;377	A;T;G	373;373;375	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	L194S	NONSYN	580	582	TTA	971	973	TCA	352;350;351	T;C,A;A	349;348,1;348	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1016	1018	CAG	350;353;349	C;A;G	344;349;346	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1037	1039	CTT	340;342;340	C;T;T	333;336;333	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1058	1060	AGT	364;368;367	A,G;G;T	343,1;346;342	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1127	1129	CCG	524;528;530	C;C,T;G	468;473,1;476	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1229	1231	TCG	628;632;634	T;C,T;G	569;572,1;577	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1400	1402	AAA	361;354;349	A;A;A	341;335;330	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1403	1405	AAG	342;339;331	A;A;G	323;318;313	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1418	1420	CAC	285;283;282	C;A;C,T	284;274;281,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1457	1459	GAA	247;245;245	G;A;A	246;245;244	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1535	1537	ACG	174;174;170	A;C;G	172;173;168	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1586	1588	ATT	236;234;233	A;T;T	213;211;211	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1589	1591	AGT	235;234;230	A;G;T	212;211;206	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1628	1630	CTA	252;256;261	C;T;A	232;234;241	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1670	1672	AAT	199;200;203	A;A;T	187;185;189	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1739	1741	TCA	267;267;268	T;C;A	256;253;254	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1763	1765	ATG	285;286;284	A;T;G	276;276;275	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2057	2059	ACC	716;719;722	A,G;C;C,A	649,2;655;657,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11790	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2591	453.0	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2153	2155	GAA	674;668;666	G;A;A	627;625;622	.	Tetracycline resistance
